CMC Development

New Chemical Entities (NCE)

 

Partner with the world’s leading peptide manufacturer for assistance in the development, production and regulatory support of your peptide active pharmaceutical ingredients (API).

Working with us, you’ll have access to our pioneering technologies and long-term expertise in chemistry manufacturing and controls (CMC) development. 

Join over 150 global GMP customer projects targeting New Chemical Entities (NCEs) that rely on our services, capabilities and products.

cmc development

Reach success with a bespoke plan

Achieve your goals with a tailored plan to meet your specific product development needs and smooth your journey to market. From manufacturing to release, we understand that each NCE project for peptides or oligonucleotides is unique, so we partner with you to make sure your product is developed in line with its individual requirements. Discover how we:

  • Supply API in appropriate and superior quality
  • Gather the necessary information for regulatory agencies
  • Facilitate quick study approval

Peptide NCEs

Reach global growth with research-grade material, refined process development and efficient GMP-grade large-scale production.

Oligonucleotide NCEs

Release the possibilities to perfect your oligonucleotide drug with our expert process development, GMP manufacturing and regulatory guidance.

Why work with us?

  • Excellence – We provide you with the highest quality products and services in the industry.
  • Expertise – unmatched long-term knowledge in chemistry manufacturing and controls (CMC) development.
  • Innovation – We’re always looking for innovative solutions to ensure you achieve more.
  • Internationally approved – trust in our GMP compliance, with facilities inspected by the FDA, EMA and Swissmedic.
  • Sustainability – we understand the importance of ethical behavior and integrity in relation to long-term business success, so we’re dedicated to improving our economic, social and environmental sustainability.

 

sustainable large scale peptide api bachem-min

What our customers are saying

"Theratechnologies is very pleased to be working with Bachem as a supplier of Tesamorelin. The experience has been very collaborative and contributed to the success of the development program all the way up to market approval. Certainly, Bachem's expertise in peptides, their professional project management and dedication to quality gives us great confidence in knowing we are with the right partner."

- Pierre Perazzelli, V.P. Pharmaceutical Development, Theratechnologies, Inc.

“Bachem is a strategic partner for all Polyphor programs including high quality large scale production of Balixafortide (POL6326) which we are advancing in a Phase III trial in combination with eribulin in patients with advanced breast cancer. Bachem’s collaborative approach with  long term “win-win” business mindset and excellent project management gives us confidence for the future of our programs.”

Gokhan Batur, CEO, Polyphor Ltd

Peptide & Oligonucleotide News

Bachem Website Press Releases 1200x800px BACHEM AND JITSUBO ENTER INTO EXCLUSIVE LICENSING AGREEMENT
09Sep2010

Bachem and Atheris collaborate on Melusine® venom peptide libraries for lead discovery
Bachem today announced that the company concluded an agreement with Atheris Laboratories to market t...

Peptide and Oligonucleotide knowledge

Our Knowledge Center has a wide variety of tools and materials for peptide and oligonucleotide chemistry.

Peptide
calculator

Click here >>

White papers

Click here >>

Peptide content
calculator

Click here >>

Brochures

Click here >>

Oligonucleotide
calculator

Click here >>

Webinars

Click here >>

You might also be interested in…

GMP
Manufacturing

Click here >>

Quality
& Regulatory

Click here >>

Innovation

Click here >>